July 4, 2024

Grifols appoints Rahul Srinivasan as new Chief Financial Officer

Download PDF
  • Srinivasan will lead Grifols’ global financial organization, taking over from Alfredo Arroyo, who recently announced his retirement after 17 years of service
  • He brings extensive experience in senior finance leadership roles encompassing advisory, global capital markets, risk management, financial planning and analysis, compliance, governance and audit
  • Srinivasan recently served as Head of EMEA Leveraged Finance and Capital Markets at Bank of America, where the team drove significant revenue growth under his leadership
  • Srinivasan, who will start on September 16, 2024, will be part of Grifols’ executive committee and report to CEO Nacho Abia and will work alongside Arroyo during a transition period to ensure a smooth transfer of duties

Barcelona, Spain, July 4, 2024 – Grifols (MCE:GRF, MCE: GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced that  Rahul Srinivasan will be its new Chief Financial Officer (CFO).

Srinivasan will lead the company’s overall financial function including planning, treasury, tax, reporting, and investor relations and sustainability. He will also be responsible for implementing effective cash-flow strategies and driving debt-management plans. He succeeds Alfredo Arroyo, who with 17 years of dedicated service to Grifols and having driven pivotal changes has recently decided to retire.

“I am thrilled to welcome Rahul to our team. He brings a wealth of knowledge and experience together with a proven track record of success,” said Nacho Abia, Grifols CEO. “Rahul’s insights, deep knowledge of corporate finance and broad experience navigating dynamic capital markets, as well as his strong performance-oriented culture, make him an extremely valuable asset for our next chapter of growth.”

Srinivasan has held numerous senior leadership roles with over 25 years of financial services experience at KPMG, Credit Suisse and Bank of America, spanning audit & assurance services, transaction services and corporate finance, mergers and acquisitions and capital markets.

Most recently he was the Head of EMEA Leveraged Finance and Capital Markets at Bank of America, where the team drove significant revenue growth under his leadership.

“I look forward to partnering with Nacho, his senior management team and the Board of this venerable institution that has made a huge difference to people’s lives with its portfolio of life-changing medicines across a wide range of therapeutic areas,” said Rahul Srinivasan.

Srinivasan will assume his new role on September 16, 2024, and will work alongside Arroyo during a transition period to ensure a smooth transfer of duties.

He is a distinguished Fellow of the Institute of Chartered Accountants in England and Wales (ICAEW), a Business Mathematics and Statistics graduate from The London School of Economics and Political Sciences and was awarded a fully sponsored Executive MBA from ENPC School of International Management (Paris, France).